Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Director
-
Stock Symbol
-
TVTX on Nasdaq
Roy D. Baynes - trading volume in the past year for Travere Therapeutics, Inc.
Class |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
Common Stock |
31K |
$682K |
$22.00 |
Feb 6, 2025 |
Direct |
|
|
Stock option (right to buy) |
0 |
|
|
Feb 6, 2025 |
Direct |
Common Stock |
|
Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.